What is the total value of India's pharmaceutical export to Hong Kong?

India exported pharmaceuticals worth $357.4K to Hong Kong across 69 verified shipments.

Who are the top Indian pharmaceutical exporters to Hong Kong?

1. CITRAL PHARMA CO., LTD. — $204.4K. 2. LONGCHEM INTERNATIONAL TRADING COMPANY LIMITED — $98.9K. 3. FAPON INTERNATIONAL LIMITED. — $36.2K. Total: 15 suppliers.

Which companies in Hong Kong import pharmaceuticals from India?

1. SYNBIOTICS LIMITED — $204.4K. 2. GIYAAN PHARMA PRIVATE LIMITED — $98.9K. 3. BHAT BIO-TECH INDIA PRIVATE LIMITED — $17.5K. 22 buyers total.

What pharmaceutical products does India export most to Hong Kong?

1. Amphotericin ($204.4K, 57.2%); 2. Potassium ($98.9K, 27.7%); 3. Immunoglobulin ($23.9K, 6.7%); 4. Protein ($11.2K, 3.1%); 5. Serum ($6.5K, 1.8%)

Why does Hong Kong import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $357.4K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Hong Kong?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Hong Kong pharmaceutical trade?

$5.2K per consignment across 69 shipments.

How many Indian pharmaceutical companies export to Hong Kong?

15 Indian companies. Largest: CITRAL PHARMA CO., LTD. with $204.4K.

How can I find verified Indian pharmaceutical suppliers for Hong Kong?

TransData Nexus covers 15 active exporters with shipment history and trade values at transdatanexus.com.

Hong Kong to India Pharmaceutical Import (2026) — $357.4K, 15 Foreign Suppliers | TransData Nexus

Hong Kong to India Pharmaceutical Import (2026) — $357.4K, 15 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Hong Kong to India

#	Formulation	Value	Share
1	Amphotericin	$204.4K	57.2%
2	Potassium	$98.9K	27.7%
3	Immunoglobulin	$23.9K	6.7%
4	Protein	$11.2K	3.1%
5	Serum	$6.5K	1.8%
6	Plasma	$6.5K	1.8%
7	Linagliptin	$2.7K	0.8%
8	Metformin	$2.7K	0.8%
9	Paclitaxel	$306	0.1%
10	Calcium	$272	0.1%
11	Nifedipine	$11	0.0%
12	Atorvastatin	$6	0.0%
13	Biotin	$5	0.0%
14	Vitamin	$0	0.0%

India imports 14+ pharmaceutical formulations from Hong Kong with a combined trade value of $357.4K. Key products include Amphotericin ($204K), Potassium ($99K), Immunoglobulin ($24K), Protein ($11K), Serum ($6K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 69 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Hong Kong to India Trade Routes

1Amphotericin$204K

2Potassium$99K

3Immunoglobulin$24K

4Protein$11K

5Serum$6K

Top Hong Kong Suppliers to India

1Citral Pharma Co., Ltd.

$204K

2Longchem International Trading Company Limited

$99K

3Fapon International Limited.

$36K

4Fapon International Limited

$9K

5Ikris Global Limited

$5K

Trade Statistics

Total Value$357K

Shipments69

Indian Exporters15

Hong Kong Buyers22

Avg Shipment$5K

Products14

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Hong Kong Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Hong Kong and India has experienced notable growth from 2022 to 2026. In 2022, the total import value was approximately $200,000 USD, with 50 shipments from 10 Hong Kong suppliers to 15 Indian buyers. By 2026, these figures had increased to a total import value of $357,000 USD, 69 shipments, 15 Hong Kong suppliers, and 22 Indian buyers. This growth reflects a strengthening trade relationship and an expanding range of pharmaceutical products exchanged between the two regions.

2Hong Kong's Role in India's Pharma Imports

Hong Kong's contribution to India's pharmaceutical imports remains modest but consistent. In 2024, Hong Kong exported pharmaceutical products worth $3.47 million USD to India, accounting for a small fraction of India's total pharmaceutical imports. The primary categories imported from Hong Kong include specialized formulations such as amphotericin, potassium compounds, immunoglobulins, and other biologics, which are essential for treating various medical conditions.

3Recent Developments

Between 2024 and 2026, there have been no significant policy changes or trade agreements specifically affecting the Hong Kong-India pharmaceutical import corridor. However, the Central Drugs Standard Control Organisation (CDSCO) has continued to enforce stringent regulations to ensure the safety and efficacy of imported pharmaceutical products. This includes regular inspections and compliance checks for products entering the Indian market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Hong Kong identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 69 verified shipments from 15 Indian exporters to 22 Hong Kong buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

15 Exporters

22 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Hong Kong to India Pharmaceutical Import

Top Pharmaceutical Formulations — Hong Kong to India

Top Pharmaceutical Products — Hong Kong to India Trade Routes

Top Hong Kong Suppliers to India

Trade Statistics

Other Import Origins

India–Hong Kong Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Hong Kong's Role in India's Pharma Imports

3Recent Developments

Top Indian Buyers from Hong Kong

Product Routes

Full Dataset Access

Hong Kong Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Hong Kong

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Hong Kong

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Hong Kong Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — Hong Kong for Indian Pharma

1India's Import Dependency

2Hong Kong Companies in India

3Outlook & Self-Reliance

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Hong Kong

1Competing Import Origins

2Hong Kong's Competitive Advantages

FAQ — India to Hong Kong Pharmaceutical Trade